Thursday - October 01, 2026

VivoSim Labs Inc. (NASDAQ: VIVS) Uses Human 3D Biology to Streamline Drug Development

United States – Sept. 22, 2026 – VivoSim Labs Inc. (NASDAQ: VIVS) is using engineered human tissues to provide pharmaceutical researchers with earlier and potentially more predictive information about experimental medicines. VivoSim’s 3D biology technology grows human liver and intestinal tissues designed to … Continue reading →